Acutus Medical Inc

NASDAQ:AFIB   3:59:42 PM EDT
17.24
+0.28 (+1.65%)
Products

Acutus Medical Receives FDA Approval To Initiate US Atrial Fibrillation IDE Trial With Acqblate Force Sensing Ablation System

Published: 05/27/2021 12:16 GMT
Acutus Medical Inc (AFIB) - Acutus Medical Receives FDA Approval to Initiate US Atrial Fibrillation Ide Trial With the Acqblate® Force Sensing Ablation System.
Acutus Medical Inc - Enrollment for Acqblate Force Af Trial is Expected to Begin in Second Half of 2021.